News / Health

Anti-AIDS Drug Reduces Risk of HIV Transmission

Multimedia

A daily dose of an antiretroviral drug used to treat AIDS patients reduced the risk of HIV transmission by nearly 44 percent in a large international study of uninfected homosexual men and transgender men who have sex with men. Scientists say that although the results are very encouraging, more studies are needed to confirm the findings among other high risk populations.

The Chemoprophylaxis for HIV Prevention in Men, or iPrEX study, recruited 2,500 HIV negative or uninfected men in Brazil, Ecuador, Peru, South Africa, Thailand and the United States in 2007 to receive the antiretroviral drug Truvada or a placebo.

Truvada is a compound made up of two widely available generic AIDS drugs - tenofavir and emtricitabine.

At the end of the 14 month study, 100 men had acquired HIV. But there were 43.8 percent fewer infections among men in the treatment group than in the group that received the sugar pill.

Watch Melinda Smith's Companion TV Report:

More striking, researchers say, was a 73 percent lower risk of infection among men who adhered most closely to the daily drug regimen.

"The bottom line is that this is a very significant finding in the quest toward developing more comprehensive ways of preventing HIV infection," said Anthony Fauci, director of the Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health, which sponsored the study led by researchers at the University of California, San Francisco.

Dr. Fauci says more studies will be conducted to learn whether the drug works just as well to prevent HIV transmission among other high-risk individuals, including heterosexuals, in countries where infection with the AIDS virus has reached near-epidemic proportions.

"Men who have sex with men, as we know, are at the higher level of risk among people who acquire HIV infection.  And so if it works in these individuals, it is very likely we will see similar results in women as well as heterosexual men," he said.

"The results are very encouraging.  And this study really represents a major advance in HIV prevention research," said Kevin Fenton, Director of the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia.

But Dr. Fenton cautions that daily doses of Truvada, which cost between $5,000 and $7,000 per year in the United States, are unlikely to be widely available in the developing world -- at least, not right away.

He says he expects researchers will begin exploring the effectiveness of using less expensive antiretroviral drugs to protect high risk individuals.

Dr. Fenton says that any drug therapy, known as preexposure chemoprophylaxis, or PrEP, will need to be combined with other well-established prevention strategies to lower the risk of HIV transmission. "The reality is that PrEP is not going to be right for everyone.  It's not 100 percent effective.  And when it is used, it will have to be used in partnership with very comprehensive monitoring, support and prevention services," he said.

Dr. Fenton says such services include regular testing for other sexually-transmitted diseases that put individuals at higher risk for HIV infection, and education about risky lifestyle behaviors, such as drug abuse and unsafe sexual practices.

An article detailing the findings of the Chemoprophylaxis for HIV Prevention in Men study is published in The New England Journal of Medicine.

You May Like

US Firms Concerned About China's New Cyber Regulations

New rules would require technology companies doing business in financial sector to hand over their source code, adopt Chinese encryption algorithms More

WHO Focus on Ebola Shifts to Ending Outbreak

Focus to be less on building facilities and more on efforts to find infected people, manage their cases, engage with communities and ensure proper burials More

US Scientist Who Conceived of Groundbreaking Laser Technology Dies

Charles Townes, Nobel laureate, laser co-creator paved way for other scientific discoveries: CDs, eye surgery, metal cutters to name a few technologies that rely on lasers More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Super Bowl Ads Compete for Eyes on TV, Webi
X
January 29, 2015 9:58 AM
Super Bowl Sunday (Feb. 1) is about more than just the NFL's American football championship and big parties to watch the game. Viewers also tune in for the world famous commercials that send Facebook and Twitter abuzz. Daniela Schrier reports on the social media rewards for America’s priciest advertising.
Video

Video Super Bowl Ads Compete for Eyes on TV, Web

Super Bowl Sunday (Feb. 1) is about more than just the NFL's American football championship and big parties to watch the game. Viewers also tune in for the world famous commercials that send Facebook and Twitter abuzz. Daniela Schrier reports on the social media rewards for America’s priciest advertising.
Video

Video Theologians Cast Doubt on Morality of Drone Strikes

In 2006, stirred by photos of U.S. soldiers mistreating Iraqi prisoners, a group of American faith leaders and academics launched the National Religious Campaign Against Torture. It played an important role in getting Congress to investigate, and the president to ban, torture. VOA's Jerome Socolovsky reports.
Video

Video Freedom on Decline Worldwide, Report Says

The state of global freedom declined for the ninth consecutive year in 2014, according to global watchdog Freedom House's annual report released Wednesday. VOA's William Gallo has more.
Video

Video As Ground Shifts, Obama Reviews Middle East Strategy

The death of Saudi Arabia’s king, the collapse of a U.S.-friendly government in Yemen and a problematic relationship with Israel’s leadership are presenting a new set of complications for the Obama administration and its Middle East policy. Not only is the U.S. leader dealing with adversaries in Iran, the Islamic State and al-Qaida, but he is now juggling trouble with traditional allies, as White House correspondent Luis Ramirez reports.
Video

Video MRI Seems to Help Diagnose Prostate Cancer, Preliminary Study Shows

Just as with mammography used to detect breast cancer, there's a lot of controversy about tests used to diagnose prostate cancer. Fortunately, a new study shows doctors may now have a more reliable way to diagnose prostate cancer for high risk patients. More from VOA's Carol Pearson.
Video

Video Smartphones About to Make Leap, Carry Basic Senses

Long-distance communication contains mostly sounds and pictures - for now. But scientists in Britain say they are close to creating additions for our smartphones that will make it possible to send taste, smell and even a basic touch. VOA’s George Putic reports.
Video

Video NASA Monitors Earth’s Vital Signs From Space

The U.S. space agency, NASA, is wrapping up its busiest 12-month period in more than a decade, with three missions launched in 2014 and two this month, one in early January and the fifth scheduled for January 29. As VOA’s Rosanne Skirble reports, the instruments being lifted into orbit are focused on Earth’s vital life support systems and how they are responding to a warmer planet.
Video

Video Saved By a Mistake - an Auschwitz Survivor's Story

Dagmar Lieblova was 14 when she arrived at Auschwitz in December 1943, along with her entire Czech Jewish family. All of them were to die there, but she was able to leave after several months due to a bureaucratic mix-up which saved her life. Now 85, with three children and six grandchildren, she says she has a feeling of victory. This report by Ahmad Wadiei and Farin Assemi, of RFE/RL's Radio Farda is narrated by RFE’s Raymond Furlong.

Circumventing Censorship

An Internet Primer for Healthy Web Habits

As surveillance and censoring technologies advance, so, too, do new tools for your computer or mobile device that help protect your privacy and break through Internet censorship.
More

All About America

AppleAndroid